Drug discovery

Biochemists working in the lab
#Drug development #Drug discovery #Drug Discovery Chemistry #Medicinal chemistry #Research & development

CAS and Torx Software partner to streamline chemistry workflows

Torx Software and CAS, a division of the American Chemical Society, have revealed that they will collbaorate to connect CAS SciFinder users through the Torx platform to streamline workflows for discovery chemistry.   CAS SciFinder is designed to provide solutions to challenges encountered in scientific research and discovery,… Read More

#News

#AI / data analytics / healthtech / informatics #Data management #Drug discovery #Life sciences #Manufacturing #PCR

The latest drug discovery product launches

Find out what’s new in the world of tools and services for the drug discovery industry with our update below.  CFX Opus Deepwell Dx Real-Time PCR System – Bio-Rad Laboratories  Bio-Rad Laboratories has launched the CFX Opus Deepwell Dx Real-Time PCR System, which offers accurate and precise quantification… Read More

#Editor's Choice #News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

CGT Webinar: Innovating for the future

On February 17 at 8am PST / 11am EST / 4pm GMT / 5pm CET, join DDW to enjoy this free webinar, Cell and gene therapy: sustaining growth and maximising opportunities. Cell and gene therapies (CGT) are transforming the way diseases are treated. As research progresses it is hoped… Read More

#News

#Antibody #Antibody-based therapeutics #Biotechnology #Drug development #Drug discovery #Genomics #Single-cell analysis

Using single-cell technology to create human antibody-based therapeutics

San Francisco-based biotechnology company Infinimmune is emerging from stealth with its $12 million seed financing. The company is co-founded by former team leaders and multi-disciplinary tool builders from 10x Genomics. Taking a human-first approach, Infinimmune is leveraging single-cell technology to create truly human antibody-based therapeutics directly derived from the… Read More

#Business & Investment #Exclusive Content

#Breast cancer #Cancer research #CAR-T #Drug development #Drug discovery #Immuno-oncology #Lung cancer #Oncology #World Cancer Day

This week in drug discovery (30 January – 3 February)

News round-up for 30 January – 3 February by DDW Digital Content Editor Diana Spencer.  As February 4 is World Cancer Day, this week’s update focuses on developments in the field of oncology. Drugs for lung cancer, lymphoma and breast cancer have received regulatory approvals, an investment boost will … Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

How to choose the most promising drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#Animal models #Animal testing #Drug discovery #Drug safety #FDA #Regulatory

What does the FDA animal testing legislation mean for drug discovery? 

As of late December 2022, the US Food and Drug Administration (FDA) no longer needs drugs to be tested in animals to receive approval, according to legislation signed by President Joe Biden1 – the Modernization Act 2.0. This news has been shared widely as a landmark moment, especially in the eyes… Read More

#Business & Investment #Exclusive Content #Opinion #Regulatory #Trends & Analysis

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry

Connected chemistry: How to choose the most promising drug candidates from your hit list

AI and machine learning (AI/ML) methods offer an alluring way to expedite the drug discovery process by delivering a large number of possible new candidates for any given therapeutic area. However, insight from medicinal chemists is still necessary to triage and prioritise the most promising molecules for synthesis, and progress… Read More

Webinar date:
Sponsored by Torx Software
#Webinars

#Drug discovery #Women in Discovery #Women in STEM

Join the ‘Shine a Spotlight’ Women in Discovery roundtable 

On 8 February 2023, this virtual session of the SciPro Women in Discovery roundtable will take place, the ‘Shine a Spotlight’ edition, covering a range of themes by a line-up of speakers. There are five speakers lined up, each with a different perspective on the industry, who will… Read More

#News

#Drug development #Drug discovery #Lab automation #Laboratory #Research services #Technology

What technologies are enabling drug discovery breakthroughs?

Download our latest eBook ‘Technology in the lab: what’s enabling drug discovery?’ sponsored by Analytik Jena. The eBook features insights and expert opinions on the solutions and technologies that are enabling drug discovery breakthroughs and assisting research and development. Download now to learn more about: The solutions helping drug… Read More

#News

#Drug development #Drug discovery #Lab automation #Laboratory #Research services #Technology

Technology in the lab: what’s enabling drug discovery?

This latest eBook sponsored by Analytik Jena features insights and expert opinions on the solutions and technologies that are enabling drug discovery breakthroughs and assisting research and development. Download this exclusive eBook to learn more about: The solutions helping drug discovery breakthroughs get to market faster and more efficiently The… Read More

#DDW eBooks #Intelligence

#AAV #Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #RNA

Keep up to date: DDW Highlights 30 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Cell and gene therapies have been making the news this week, as… Read More

#News

#Drug development #Drug discovery #Life sciences #Lithuania #Start-ups

What Lithuania offers life sciences start-ups

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong takes a look at Lithuania’s life sciences sector and what it means for start-ups operating in the country. A one to watch, would be my first thoughts when thinking about Lithuania and its start-up sector. After… Read More

#Exclusive Content #Start-up Zone

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar: Transforming disease treatment with CGT

Register to attend Cell and gene therapy: sustaining growth and maximising opportunities, a free-to-attend DDW webinar, supported by Benchling and BPS Bioscience, on February 17, 2023 at 8am PST / 11am EST / 4pm GMT / 5pm CET.  Cell and gene therapies (CGT) are transforming the way diseases… Read More

#News

#AAV #Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #RNA

This week in drug discovery (23-27 January)

News round-up for 23-27 January by DDW Digital Content Editor Diana Spencer. Cell and gene therapies have been making the news this week, as we launch our very own guide to global… Read More

#News

Protein degradation
#Biology #CRO #Drug development #Drug discovery #Genomics #Protein chemistry / Proteomics #Therapeutics

New podcast on CROs and targeted protein degradation

This is the latest episode of the free narrated DDW podcast, “CROs and targeted protein degradation offer an exciting future”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “CROs: Drug discovery expertise on hand” and “Why the emergence… Read More

#News